Skip to main content
Premium Trial:

Request an Annual Quote

Beckman's Stock Drops on Missed Q2 Targets

NEW YORK (GenomeWeb News) – Shares in Beckman Coulter were down approximately 7.7 percent, or $4.39, at $52.61 in mid-afternoon trading today after the company reported a decrease in second-quarter sales and net income.
 
As reported by GenomeWeb News this morning, total revenues declined to $616 million, from $619 in the same period last year. Beckman blamed the lower-than-expected revenues on lagging sales in the Asian market.
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.